The extension, released shortly before the flexibilities were set to expire at the end of 2025, gives regulators more time to ...
This interview addresses the challenges and complexities of developing and manufacturing controlled-release drug formulations. Could you introduce yourself and your expertise in drug development and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback